Bitcoin News

Bitcoin Responds To Pfizer COVID-19 Vaccine Reports

Markets look volatile as Pfizer Inc. and BioNTech SE share details of a vaccine against SARS-CoV-2 that is 90% effective.

Pfizer and BioNTech’s vaccine announcement for preventing COVID-19 has shaken Bitcoin and equities markets. 

COVID Vaccine Tested on Tens of Thousands

Today, pharma giants shared details of a treatment effective in 90% of vaccine candidates, following an in-depth study of 43,538 participants. 

The trials evaluated 94 confirmed cases of COVID-19. It’s by far the closest treatment to a COVID-19 vaccine announced so far, and markets have responded shakily. 

Pfizer’s shares rose by around 7% when the announcement dropped, while BioNTech American’s depositary receipts are up 11%. SPX futures also jumped 3%. 

Meanwhile, Bitcoin raised questions over its performance in a risk-on climate, jumping in correlation with other assets within minutes of the news, before dipping back to a higher low of around $15,500. 

Ether followed Bitcoin’s trajectory. Gold has also dropped, suggesting that many market participants are unsure how to price in the news. 

Crypto products and NFTs are unregulated and can be highly risky. There may be no regulatory recourse for any loss from such transactions. Crypto is not a legal tender and is subject to market risks. Readers are advised to seek expert advice and read offer document(s) along with related important literature on the subject carefully before making any kind of investment whatsoever. Crypto market predictions are speculative and any investment made shall be at the sole cost and risk of the readers.